Argomento

Indietro Interim Considerations: Preparing for the Potential Management of Anaphylaxis after COVID-19 Vaccination

Summary of recent changes (last updated February 11, 2022)

  • Added table for potential characteristics of allergic reactions, vasovagal reactions, and vaccine side effects following COVID-19 vaccination.

Key Points

  • Anaphylaxis, an acute and potentially life-threatening allergic reaction, has been reported rarely following COVID-19 vaccination.
  • Under the Emergency Use Authorizationsexternal icon for COVID-19 vaccines, appropriate medical treatment for severe allergic reactions must be immediately available at any site administering the vaccine in the event that an acute anaphylactic reaction occurs following administration of a COVID-19 vaccine.
  • These interim considerations provide information on preparing for the initial assessment and potential management of anaphylaxis following COVID-19 vaccination.

Entire content available on: https://www.cdc.gov/vaccines/covid-19/clinical-considerations/managing-anaphylaxis.html